Is a complete DNTH research report available?

No complete published report is available for Dianthus Therapeutics, Inc. (DNTH) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · USD

$105

+2.03 (+2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DNTH analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.7B
Revenue (ttm)	1.3M
Net income (ttm)	-173.7M
EPS (ttm)	-$4.17
Shares out	54.7M
Volume	883,974
Beta	0.09
Price target	$129	+22.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -173.7M
EPS (ttm): -$4.17
Market cap: 5.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DNTH indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001690585
Company name	Dianthus Therapeutics, Inc.
Country	United States
Country code	US
Cusip	252828108
Employees	92
Employees Change	14%
Employees Change Percent	17.95
Enterprise value	$4.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US2528281080
Last refreshed	2026-07-24
Market cap	$5.7B
Market cap category	Mid-Cap
Price	$105
Price currency	USD
Rev Per Employee	14,521.74x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	DNTH
Website	https://dianthustx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.03%
EV Sales Forward	4,128.97x
EV/Sales	3,371.79x
FCF yield	-2.28%
P/B ratio	4.76x
P/S ratio	4,287.78x
PS Forward	5,250.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-14,318.04%
EBITDA Margin	-14,309.36%
Gross margin	100%
Gross Profit	$1.3M
Gross Profit Growth	-79.52%
Gross Profit Growth Q	-60.19%
Gross Profit Growth3 Y	-39.48%
Net Income	$-173.7M
Net Income Growth Years	0%
Pretax Margin	-12,998.5%
Profit Per Employee	$-1.9M
ROA	-14.99
ROCE	-15.83
ROE	-22.7
ROIC	-15.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	405.82%
EPS Growth Years	0
Revenue Growth	-79.52x
Revenue Growth Q	-60.19x
Revenue Growth Years	0x
Revenue Growth3 Y	-39.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$1.2B
Cash	$1.1B
Current Assets	$1.1B
Current Liabilities	$38.3M
Debt	$1.4M
Debt Equity	$0
Equity	$1.2B
Liabilities	$45.6M
Long Term Assets	$127M
Long Term Liabilities	$7.3M
Net Cash	$1.2B
Net Cash By Market Cap	$21.36
Net Cash Growth	270.68%
Net Debt Equity	$-1.02
Tangible Book Value	$1.2B
Tangible Book Value Per Share	$22.01
WACC	4.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	29.25
Net Working Capital	$-29.2M
Quick ratio	29.06
Working Capital	$1.1B
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	405.26%
200-day SMA	64.51
50-day SMA	90.24
50-day SMA vs 200-day SMA	50over200
All Time High	108
All Time High Change	-2.96%
All Time High Date	2026-07-20
All Time Low	6.58
All Time Low Change	1,492.55%
All Time Low Date	2023-12-19
ATR	6.01
Beta	0.09
Beta1y	-0
Beta2y	0.9
Ch YTD	154.3
High	106.6
High52	108
High52 Date	2026-07-20
High52ch	-2.96%
Low	100.1
Low52	18.08
Low52 Date	2025-08-11
Low52ch	479.59%
Ma50ch	16.12%
Premarket Change Percent	1.09
Premarket Price	$104
Premarket Volume	340
Price vs 200-day SMA	62.43%
RSI	60.21
RSI Monthly	85.76
RSI Weekly	74.25
Sharpe ratio	2.72x
Sortino ratio	5.41
Total Return	-16.27%
Tr YTD	154.3
Tr1m	19.94%
Tr1w	9.9%
Tr3m	14.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	13
Analyst Price Target Top	$129
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.91
Earnings Revenue Estimate	293,000x
Earnings Revenue Estimate Growth	51.81x
Operating Income	$-191.3M
Operating margin	-14,318
Price target	$129
Price Target Change	$22.7
Price Target Change Top	$23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,596,941%
Float Percent	99.87%
Shares Insiders	0.13%
Shares Institutions	122.8%
Shares Out	54,666,233
Shares Qo Q	6.81%
Shares Yo Y	16.27%
Short Float	17.46%
Short Ratio	6.36
Short Shares	17.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-158.6M
Average Volume	1,278,960.2x
Bv Per Share	22.01
CAPEX	$-199,000
Ch1m	19.94
Ch1w	9.9
Ch1y	405.3
Ch3m	14.79
Ch6m	98.62
Change	1.98%
Change From Open	3.72
Close	102.8
Days Gap	-1.68
Depreciation Amortization	116,000
Dollar Volume	92,631,635.5
Earnings Date	2026-08-04
Earnings Time	amc
EBIT	$-191.3M
EBITDA	$-191.2M
EPS	$-4.17
F Score	2
FCF	$-130.5M
FCF EV Yield	-2.9x
FCF Per Share	$-2.39
Financing CF	1,019,374,000
Fiscal Year End	December
Founded	2,015
Investing CF	-271,600,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	73.3
Ma150ch	42.97%
Ma20	98.22
Ma20ch	6.68%
Net CF	617,488,000
Next Earnings Date	2026-08-07
Open	101
Optionable	Yes
Position In Range	72.56
Post Close	104.8
Postmarket Change Percent	1.57
Postmarket Price	$106
Ppne	1,567,000
Pre Close	102.8
Price Date	2026-07-23
Ptbv Ratio	4.77
Relative Volume	0.69x
Revenue	1,336,000x
SBC By Revenue	2,101.8x
Share Based Comp	28,080,000
Tr6m	98.62%
Us State	New York
Volume	883,974
Z Score	19.1

Dianthus Therapeutics, Inc. (DNTH)

Coverage state: Market snapshot only — no published research

Generate the first DNTH analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DNTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DNTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DNTH

Frequently asked questions